ARGAN INC
AGXOther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|---|
| Revenue | $944.6M | $874.2M | $573.3M | $455.0M | $509.4M | $392.2M |
| Operating income | $134.7M | $88.2M | $36.5M | $41.7M | $44.5M | $23.0M |
| Net income | $137.8M | $85.5M | $32.4M | $33.1M | $38.2M | $23.9M |
| Total assets | $1.19B | $836.2M | $598.2M | $489.5M | $553.6M | $602.6M |
| Total liabilities | $724.1M | $484.4M | $307.3M | $208.6M | $228.0M | $280.2M |
| Equity | $462.3M | $351.9M | $290.9M | $280.9M | $326.4M | $320.7M |
| EPS (diluted) | $9.74 | $6.15 | $2.39 | $2.33 | $2.40 | $1.51 |
| Shares out. | 13.9M | 13.6M | 13.2M | 13.4M | 14.8M | 15.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- 14.3%
- Net margin
- 14.6%
- Return on equity
- 29.8%
- Return on assets
- 11.6%
- Return on capital (ROCE)
- 28.4%
- Liabilities / assets
- 61.0%
- Debt / equity
- 1.57×
- Book value / share
- $33.15
- Revenue growth (YoY)
- 8.1%
- Net income growth (YoY)
- 61.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Altman Z″ (distress)
- 4.88safe
- Accruals / assets
- −23.3%clean
- Beneish M-Score
- -4.03normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 6 good- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- First Trust Portfolios LpPassive (13G)Apr 27, 2026
- Blackrock, Inc.Passive (13G)Apr 7, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Wellington Management Group LlpPassive (13G)Feb 10, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Larroque Alexander LisaDirector | Apr 29, 2026 | Sell | 350 | $630.58 |
| Getsinger Peter WDirector | Apr 29, 2026 | Sell | 3,000 | $628.36 |
| Leimkuhler William F.Director | Apr 28, 2026 | Sell | 5,000 | $617.41 |
| Jeffrey John Ronald Jr.Director | Apr 27, 2026 | Sell | 2,698 | $664.84 |
| Collins Charles Edwin IvOfficer — CHIEF EXECUTIVE OFFICER, GEMMA | Apr 20, 2026 | Option exercise | 2,500 | $39.47 |
| Jeffrey John Ronald Jr.Director | Apr 21, 2026 | Sell | 3,636 | $615.40 |
| Collins Charles Edwin IvOfficer — CHIEF EXECUTIVE OFFICER, GEMMA | Apr 16, 2026 | Option exercise | 548 | $0.00 |
| Watson David HibbertOfficer — PRESIDENT AND CEO | Apr 16, 2026 | Option exercise | 1,869 | $0.00 |
| Baugher Joshua ScottOfficer — Chief Financial Officer | Apr 16, 2026 | Option exercise | 509 | $0.00 |
| Larroque Alexander LisaDirector | Apr 16, 2026 | Option exercise | 700 | $0.00 |
| Leimkuhler William F.Director | Apr 13, 2026 | Sell | 8,444 | $598.49 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 642,297 | 2.2 | -18.5% |
| Apr 30, 2026 | 788,159 | 2.5 | -12.3% |
| Apr 15, 2026 | 898,807 | 2.9 | +13.0% |
| Mar 31, 2026 | 795,305 | 1.0 | +38.6% |
| Mar 13, 2026 | 573,972 | 1.3 | -5.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventApr 8, 2026
- Results of operationsMar 26, 2026
- Other material eventDec 11, 2025
- Results of operationsDec 4, 2025
- Other material eventNov 7, 2025
- Other material eventOct 30, 2025
- Other material eventSep 10, 2025
- Results of operationsSep 4, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.